Increasing the dosage had no effect beyond the initial dose, even though the molarity of epinephrine was increased by 350%.
Aukaskammtarnir höfðu engin umframáhrif fram yfir upphaflega skammtinn, jafnvel þótt aukaskammturinn yki mólstyrk adrenlíns baðsins um allt að 350%.